Aura Biosciences Inc

NASDAQ:AURA   3:59:50 PM EDT
19.15
+1.04 (+5.74%)
Other Pre-Announcement

Aura Biosciences Reports Third Quarter 2021 Financial Results And Provides Clinical Development And Operational Highlights

Published: 11/24/2021 21:15 GMT
Aura Biosciences Inc (AURA) - Aura Biosciences Reports Third Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights.
Aura Biosciences Inc - Believes Current Cash and Cash Equivalents Are Sufficient to Fund Company's Operations Into 2024.
Aura Biosciences Inc - Qtrly Net Loss per Share Attributable to Common Stockholders, Basic and Diluted $28.33.